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PKChIn this study, we revealed that GCN5 and early B cell factor 1 (EBF1) participate in regulation of pro-
tein kinase Ch (PKCh) gene expression in an opposite manner in immature B cells. GCN5-deﬁciency in
DT40 caused drastic down-regulation of transcription of PKCh. In contrast, EBF1-deﬁciency brought
about remarkable up-regulation of that of PKCh, and re-expression of EBF1 dramatically suppressed
transcription of PKCh. Chromatin immunoprecipitation assay revealed that GCN5 binds to the
50-ﬂanking region of the chicken PKCh gene and acetylates histone H3, and EBF1 binds to the
50-ﬂanking region of the gene surrounding putative EBF1 binding motifs.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein kinase Cs (PKCs) are involved in various cell functions
(proliferation, differentiation, cell survival and apoptotic cell
death) via phosphorylation of proteins regulating signal transduc-
tion pathways [1]. Ten isoforms of PKCs have been found and are
classiﬁed into three subfamilies: conventional Ca2+-dependent iso-
forms (a, bI/II and c), novel Ca2+-independent isoforms (d, e, g and
h) and atypical isoforms (i and f) [2]. Among them, PKCa, bI/II, d, e,
i and f are widely expressed in many different cells and tissues [3].
In contrast, other isoforms show tissue-speciﬁc expression pat-
terns. For instance, PKCc is restricted to brain and neuronal tissues
[4], PKCg is largely expressed in epithelial tissues and epithelia [5],and PKCh is predominantly found in skeletal muscle and T cells,
and also reported to play important and speciﬁc roles in T cells
[6,7]. However, the understanding of tissue-speciﬁc transcriptional
regulation mechanisms of PKC isoforms, which control their tissue-
speciﬁc distributions, are still poor in vertebrates.
Histone acetylation regulated by histone acetyltransferases
(HATs) and histone deacetylases plays critical roles in the modula-
tion of chromatin topology and thereby epigenetic control of gene
expressions [8,9]. To investigate physiological roles of GCN5, a pro-
totypical HAT [10], we generated homozygous GCN5-deﬁcient
DT40 (a chicken immature B cell line) mutants, GCN5/ [11].
Our previous studies of GCN5/ revealed that GCN5-deﬁciency
causes drastic resistance against B cell receptor (BCR)-mediated
apoptosis via transcriptional regulation of various apoptosis-
related genes including PKC isoforms [12]. On the other hand,
the normal progression of B cell differentiation in vertebrates re-
quires numerous speciﬁc transcription factors [13]. Gene targeting
techniques in DT40 are surely excellent methods to study physio-
logical roles of transcription factors in immature B cells [14,15].
We previously reported that Aiolos and Helios regulate apoptotic
cell death mediated by BCR stimulation through transcriptional
regulation of PKC isoforms, such as PKCd, PKCe, PKCg and PKCf
1740 H. Kikuchi et al. / FEBS Letters 588 (2014) 1739–1742[16,17]. These results showed that HATs and B cell development-
related transcription factors can control gene expressions of PKC
isoforms in B cells.
In this study, we studied regulation mechanism of PKCh gene
expression in B cells, since PKCh is also expressed in B cells and
plays an important role in B cell activation via BCR-signaling
[12,18,19]. GCN5-deﬁciency caused drastic down-regulation of
the transcription of PKCh. In contrast, lack of early B cell factor 1
(EBF1), a transcription factor essential for B cell development,
brought about remarkable up-regulation of the transcription of
PKCh. These results, together with those obtained by chromatin
immunoprecipitation (ChIP) assay, revealed that EBF1 and GCN5
participate in regulation of PKCh gene expression in an opposite
manner in immature B cells.A
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2.1. Cell cultures and immunoblotting
Generation of GCN5/ and EBF1/ was described in our previ-
ous reports [11,15]. Immunoblotting using anti-PKCh antibody
(Abcam, Cambridge, UK) was performed as described [11]. b-Actin
was used as control.
2.2. Semiquantitative reverse transcription-polymerase chain reaction
(RT-PCR)
RT-PCR was carried out essentially as described [11,12,16,
17,20–22]. PCRs were carried out using chicken PKCs primers listed
in the previous report [12]. Glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) was used as internal control. PCR products were
subjected to 1.5% agarose gel electrophoresis. Data obtained by
semiquantitative RT-PCR before reaching the plateau were analyzed
by Image Gauge software Proﬁle mode (densitometric analysis
mode) using a luminescent image analyzer LAS-1000plus (Fujiﬁlm,
Tokyo, Japan).PKCε
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**2.3. 50-Rapid ampliﬁcation of cDNA ends (50-RACE)
Transcription initiation site of the chicken PKCh gene was deter-
mined by 50-RACE using a SMARTer™ RACE cDNA Ampliﬁcation Kit
(Clonetech Laboratories, Inc., Mountain View, CA, USA) according
to manufacturer0s instructions. The oligonucleotides 50-GCCCTTGC
CGTGCAAGGCCCCAGAGCAG-30 and 50-CCTCCCCTTGGGATGGCAGG
TAAGGGCC-30 were used as primers for ﬁrst PCR and nested PCR,
respectively.PKCθ
β-actin
80K
46K
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Fig. 1. GCN5-deﬁciency causes drastic down-regulation of PKCh gene expression.
(A) Semiquantitative RT-PCR. mRNA levels of PKCs in three independent GCN5/
clones and parental GCN5+/+ (DT40) were determined by semiquantitative RT-PCR.
GAPDH was used as internal control for calibration. Data represent averages of
three independent GCN5/ clones (solid bars), and are indicated as percentages of
control values (100%) obtained from GCN5+/+ cells (gray bars). Error bars indicate
S.D. Statistical differences were calculated using t test. ⁄⁄P < 0.01. (B) Immunoblot-
ting. Protein samples were prepared from three independent GCN5/ clones and
GCN5+/+, and subjected to 7.5% SDS–PAGE followed by immunoblotting using anti-
PKCh antibody. b-Actin was used as control. Typical immunoblotting patterns are
shown.2.4. ChIP assay
ChIP assay was performed using Chromatin Immunoprecipita-
tion Assay Kit (Millipore, Billerica, MA, USA) as described [20–
23]. Immunoprecipitation with anti-GCN5 antibody (Chemicon,
Temecula, CA, USA), anti-acetylated histone antisera (Millipore)
or anti-Flag M2 antibody (Sigma–Aldrich, St. Louis, MO, USA) was
carried out. Immunoprecipitated and input DNAs were analyzed
by PCR using ChIP primers (sense 50-ATGGCTGGACAAGACGCTCA-
30 and antisense 50-ACTGCCCTCAATGCCTCTTC-30) corresponding
to 50-upstream region of the chicken PKCh gene. PCRs using KOD
FX DNA polymerase (Toyobo, Osaka, Japan) were carried out at
98 C for 20 s, 55 C for 20 s and 68 C for 30 s for 31–34 cycles,
and stopped before reaching the plateau. PCR products were sub-
jected to 1.5% agarose gel electrophoresis and analyzed using
LAS-1000plus as described above.3. Results and discussion
3.1. GCN5-deﬁciency causes drastic down-regulation of PKCh at both
mRNA and protein levels
To investigate effects of GCN5-deﬁciency on gene expressions of
PKCs, we ﬁrst carried out semiquantitative RT-PCR on total RNAs
prepared from three independent GCN5/ clones and parental
GCN5+/+ (DT40) cells (Fig. 1A). GCN5-deﬁciency moderately or
drastically down-regulated transcriptions of PKCg (to 50%) or
PKCh (to 1%), and obviously up-regulated those of PKCa (to
300%), PKCd (to 1200%), PKCe (to 600%) and PKCf (to
1000%). Because GCN5 is generally considered to directly partic-
ipate in up-regulation of target genes as a transcriptional co-acti-
vator with intrinsic HAT activity [24], next, we focused on PKCh
whose transcription was drastically down-regulated in GCN5/,
and examined inﬂuences of GCN5-deﬁciency on the protein level
of PKCh by immunoblotting (Fig. 1B). As expected, GCN5-deﬁciency
caused drastic decreases in protein level of PKCh in accordance
with the down-regulation of its mRNA level. These results, to-
gether, revealed that GCN5 participates preferentially in regulation
of PKCh gene expression.
3.2. GCN5 binds to the 50-ﬂanking region of the PKCh gene and
acetylates Lys-9 of histone H3
We examined by ChIP assay whether or not GCN5 interacts with
regulatory region of the chicken PKCh gene. First, to determine its
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Fig. 3. EBF1 suppresses gene expression of PKCh and interacts with its 50-ﬂanking
region. (A) Involvement of EBF1 in chicken PKCh gene expression. Total RNAs were
extracted from parental EBF1+/+ (gray bar), EBF/ (solid bar) and EBF1//EBF1
(striped bars), and mRNA level of PKChwas determined by semiquantitative RT-PCR
using appropriate primers. GAPDH was used as internal control. Data calibrated
with the internal control are indicated as percentages of control values (100%)
obtained from EBF1+/+ and represent the averages of three separate experiments.
Error bars indicate S.D. Statistical differences were calculated using t test. ⁄⁄P < 0.01.
(B) Interaction of EBF1 with the 50-ﬂanking region surrounding putative EBF1
binding motifs of chicken PKCh gene. The cross-linked chromatins from cell lysates
of EBF1/ and EBF1//EBF1 were co-precipitated by anti-Flag M2 antibody. Anti-
Flag M1 antibody was used as negative control. After decross-linking, co-precip-
itated chromatins and input samples were ampliﬁed by PCR using ChIP primers.
PCR products were analyzed by 1.5% agarose gel electrophoresis. Typical patterns
are shown.
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revealed that the transcription initiation site G was located at the
position indicated in Fig. 2A. Signiﬁcantly, a GC box (33 to 38)
and a CAAT box (139 to 143) were found in the 50-ﬂanking re-
gion of the gene. Next, we performed ChIP assay using anti-GCN5
antibody and anti-acetylated histone antisera (Lys-9 of histone
H3 (H3K9) and Lys-14 of histone H3 (H3K14)). These two Lys res-
idues of histone H3 are typical acetylation sites catalyzed by GCN5
[10,20–23,25]. Precipitated chromatins were ampliﬁed by PCR
using ChIP primers for the 50-ﬂanking region of the chicken PKCh
gene (Fig. 2A). Concerning GCN5, as expected, ampliﬁed DNA frag-
ment could be detected in GCN5+/+ but not in GCN5/ (Fig. 2B).
Regarding acetylated histones, acetylation of H3K9 within chroma-
tin surrounding the 50-ﬂanking region of the gene was drastically
decreased in GCN5/ (to 10% of control value obtained from
GCN5+/+), whereas GCN5-deﬁciency showed insigniﬁcant effect on
acetylation of H3K14 (Fig. 2C). For both GCN5 and acetylated his-
tones, similar results were obtained using two other GCN5/
clones (data not shown). These data revealed that GCN5 binds to
the 50-ﬂanking region of the chicken PKCh gene and acetylates
H3K9 residue, suggesting that gene expression of PKCh is certainly
up-regulated by GCN5 in immature B cells.
3.3. EBF1 down-regulates gene expression of PKCh
It is noteworthy that ﬁve putative EBF1-binding motifs [26] ex-
ist in the 50-ﬂanking region of the chicken PKCh gene (see Fig. 2A).
To know whether or not EBF1 is involved in gene expression of
PKCh, semiquantitative RT-PCR was performed on total RNAs pre-
pared from parental EBF1+/+ (DT40), homozygous EBF1-deﬁcient
DT40 mutant EBF1/ and EBF1-re-expressed EBF1//EBF1, which
expresses the EBF1 gene in large excess (500%) compared to
EBF1+/+ (DT40) [23]. While transcription of PKCh was remarkablyirrelevant   anti- irrelevant  anti-  
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Fig. 2. GCN5 binds to chicken PKCh gene and acetylates H3K9 residues within its 50-ﬂanking chromatin region. (A) Schematic diagram for the 50-ﬂanking region of chicken
PKCh gene. The transcription start site of chicken PKCh gene determined by 50-RACE is indicated by an arrow. GC box, CAAT box and ﬁve putative EBF1-binding motifs are
underlined. Forward- and reverse-primers used for PCR in ChIP assay are shown. (B) Interaction of GCN5 with the 50-ﬂanking region of chicken PKCh gene. Co-precipitated
chromatin with anti-GCN5 antibody or control IgG (ChIP) and input samples (Input) were ampliﬁed by PCR. Typical patterns are shown. (C) Acetylation levels of Lys residues
of histone H3 within chromatin surrounding the 50-ﬂanking region of chicken PKCh gene. ChIP assay was performed using antisera speciﬁc for acetylated H3K9 (Ac-H3K9) and
H3K14 (Ac-H3K14). Cross-linked chromatins of parental GCN5+/+ (open bars) and GCN5/ (gray bars) were co-precipitated by antisera speciﬁc for acetylated H3K9 and
H3K14 residues. Upper panel: Data are indicated as percentages of control values (100%) obtained from GCN5+/+ and represent the averages of three separate experiments.
Error bars indicate S.D. Statistical differences were calculated using t test. ⁄⁄P < 0.01. Lower panel: Typical PCR patterns using co-precipitated chromatin with antisera or
normal sera (ChIP) and input samples (Input) are shown.
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lated (to 15%) in EBF1//EBF1 (Fig. 3A), suggesting that EBF1
negatively regulates gene expression of PKCh in immature B cells.
Next, we examined whether or not EBF1 interacts with regulatory
region of the PKCh gene by ChIP assay. Because chicken endoge-
nous EBF1 could not be detected by available anti-EBF1 antibodies,
we used anti-Flag M2 antibody instead of the antibodies [23]. Pre-
cipitated chromatins were ampliﬁed by PCR using the ChIP primers
on the proximal 50-upstream region of the PKCh gene surrounding
these putative EBF1 binding motifs (see Fig. 2A). Ampliﬁed DNA
fragment could be detected in EBF1//EBF1 but not in EBF1/
(Fig. 3B). Thus, EBF1 binds to the 50-ﬂanking region of the PKCh
gene surrounding the putative EBF1 binding motifs in vivo, sug-
gesting that gene expression of PKCh is certainly down-regulated
by EBF1 in immature B cells.
3.4. Concluding remarks
PKCs play very important roles in B cell activation through sig-
nal transduction including BCR-mediated signaling [19,27–29]. As
mentioned above, among 10 isoforms of PKCs, several isoforms
show tissue-speciﬁc distributions. As a result, PKC signaling path-
way is complicated in each tissue and cell. However, the knowl-
edge of tissue-speciﬁc gene regulation mechanisms, which
control the tissue-speciﬁc distributions of PKCs is still poor in ver-
tebrates so far. This is the ﬁrst report that PKCh gene expression in
B cells is up- and down-regulated by GCN5 and EBF1, respectively.
On the other hand, recently, PKC isozymes have been remarked as
attractive targets for drug discovery because there are evidences
for critical roles of PKCs in many important human diseases includ-
ing autoimmune diseases and leukemia [30]. Therefore, to know
the relevance of our ﬁndings to these diseases, we referred to var-
ious human databases (e.g. RIKEN FANTOM database). Unfortu-
nately, we could ﬁnd the transcription initiation sites of PKCh in
various tissues such as liver, cerebrum, kidney, large intestine,
small intestine, skin, cecum and adipose, but not B cells. Further-
more, data obtained from the open databases revealed that these
initiation sites are remarkably varied among various human tissue
types. Consequently, as a ﬁrst step to discover drugs speciﬁc for
these diseases, it is important to know tissue-speciﬁc mechanisms
of gene expressions of PKC isozymes, including the transcription
initiation sites, in vertebrates including mammalians. Our results
in this study, together with our previous reports [12,16,17], may
signiﬁcantly contribute to the understanding of gene regulations
of PKCs, resulting in developing effective therapies for diseases
caused by catastrophe of PKC-mediated signaling.
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